Amyloidosis is a shared name for several rare, complex and serious diseases caused by
extra-cellular deposits of different misfolded proteins. Accurate characterization of the …

Mass spectrometry (MS)-based proteomics can directly identify amyloid deposits. We
describe successful proteomic amyloid typing in fat aspirates in which immunoelectron …

The tissue diagnosis of amyloidosis and confirmation of fibril protein type, which are crucial
for clinical management, have traditionally relied on Congo red (CR) staining followed by …

Amyloidoses are characterized by deposition of misfolded proteins as β‐pleated sheet fibrils
in organs. Despite the similar morphologic appearance of fibrils, at least 28 different proteins …

Amyloidoses are characterized by the presence of extracellular amyloid deposits,
constituted by fibrillar aggregates of misfolded proteins. Despite the similar morphologic …

Amyloidosis is caused by deposition in tissues of abnormal protein in a characteristic fibrillar
form. There are many types of amyloidosis, classified according to the soluble protein …

Amyloidosis is a heterogeneous group of protein misfolding diseases characterized by
deposition of amyloid proteins. The kidney is frequently affected, especially by …

Amyloidosis comprises a spectrum of disorders characterized by the extracellular deposition
of amorphous material, originating from an abnormal serum protein. The typing of amyloid …

We have determined patient's amyloid subtype through immunohistochemical and
proteomic analyses of formalin‐fixed, paraffin‐embedded (FFPE) tissue samples from two …

Amyloidosis refers to a clinically heterogeneous group of disorders characterized by the
extracellular deposition of amyloid proteins in various tissues of the body. To date, 42 …